These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1681053)

  • 1. Initial and steady state pharmacokinetics of cilazapril in congestive cardiac failure.
    Wiseman MN; Elstob JE; Francis RJ; Brown AN; Rajaguru S; Steiner J; Dymond DS
    J Pharm Pharmacol; 1991 Jun; 43(6):406-10. PubMed ID: 1681053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacokinetic study of cilazapril in patients with congestive heart failure.
    Rosenthal E; Francis RJ; Brown AN; Rajaguru S; Williams PE; Steiner J; Curry PV
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):267S-273S. PubMed ID: 2548554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics and angiotensin converting enzyme inhibition dynamics of cilazapril in essential hypertension.
    Meredith PA; Elliott HL; Reid JL; Francis RJ
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):263S-266S. PubMed ID: 2548553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cilazapril during repeated oral dosing in healthy young volunteers.
    Williams PE; Brown AN; Rajaguru S; Francis RJ; Bell AJ; Dewland PM
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):63-7. PubMed ID: 2166672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease.
    Deget F; Brogden RN
    Drugs; 1991 May; 41(5):799-820. PubMed ID: 1712710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics and dose proportionality of cilazapril.
    Massarella J; DeFeo T; Lin A; Limjuco R; Brown A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):199S-204S. PubMed ID: 2527533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal and impaired renal function.
    Shionoiri H; Gotoh E; Takagi N; Takeda K; Yabana M; Kaneko Y
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):242-9. PubMed ID: 2452321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilazapril in congestive heart failure. A pilot study.
    Kiowski W; Drexler H; Meinertz T; Zuber M; Ritz R; Burkart F; Just H
    Drugs; 1991; 41 Suppl 1():54-61. PubMed ID: 1712273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics and bioavailability of cilazapril in normal man.
    Williams PE; Brown AN; Rajaguru S; Francis RJ; Walters GE; McEwen J; Durnin C
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):181S-188S. PubMed ID: 2527531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cilazapril in patients with renal failure.
    Fillastre JP; Moulin B; Godin M; Williams PE; Brown AN; Francis RJ; Pinta P; Manfredi R
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):275S-282S. PubMed ID: 2527539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacokinetic study of cilazapril in elderly and young volunteers.
    Williams PE; Brown AN; Rajaguru S; Walters GE; McEwen J; Durnin C
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):211S-215S. PubMed ID: 2527535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of food on the pharmacokinetics and ACE inhibition of cilazapril.
    Massarella JW; DeFeo TM; Brown AN; Lin A; Wills RJ
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):205S-209S. PubMed ID: 2527534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of single and consecutive doses of cilazapril and its depressor effects in hypertensive patients with renal dysfunction.
    Shionoiri H; Gotoh E; Miyakawa T; Takasaki I; Oda H; Ueda S; Kaneko Y
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):230S-232S. PubMed ID: 2843197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary vasodilatation and improved myocardial lactate metabolism after angiotensin converting enzyme inhibition with cilazapril in patients with congestive heart failure.
    Kiowski W; Zuber M; Elsasser S; Erne P; Pfisterer M; Burkart F
    Am Heart J; 1991 Nov; 122(5):1382-8. PubMed ID: 1683143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state pharmacokinetics and pharmacodynamics of cilazapril in the presence and absence of cyclopenthiazide.
    Krum H; Jackson B; Conway EL; Howes LG; Johnston CI; Louis WJ
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):451-7. PubMed ID: 1279292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the pharmacokinetics and pharmacodynamics of cilazapril between Chinese and Caucasian healthy, normotensive volunteers.
    Anderson PJ; Critchley JA; Tomlinson B
    Eur J Clin Pharmacol; 1996; 50(1-2):57-62. PubMed ID: 8739812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal or impaired renal function.
    Shionoiri H; Gotoh E; Sugimoto K; Takasaki I; Minamisawa K; Ishii M
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):283S-287S. PubMed ID: 2527540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and effects on renal function following cilazapril and hydrochlorothiazide alone and in combination in healthy subjects and hypertensive patients.
    Nilsen OG; Sellevold OF; Romfo OS; Smedsrud A; Grynne B; Williams PE; Kleinbloesem CH
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):323S-328S. PubMed ID: 2527546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive treatment with cilazapril. Resting and exercise blood pressure, hormones and enzymes.
    Breithaupt K; Belz GG; Spielmanns DG; Neis W; Kirchner P
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):136-41. PubMed ID: 2159308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intravenous cilazaprilat in normal volunteers.
    Whitehead EM; Walters GE; Williams PE; Johnston GD
    Br J Clin Pharmacol; 1989 Jun; 27(6):873-5. PubMed ID: 2757899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.